Guest guest Posted October 15, 2002 Report Share Posted October 15, 2002 Stacey, the side-effect profile of D2E7 will probably be similar to those of Enbrel and Remicade since all three are TNF-alpha inhibitors. They are expecting fewer side-effects with D2E7 (adalimumab) than Remicade since it is " fully human " (no mouse parts). We'll see. Check this out: " The most frequent side effects were injection site reactions, which were three- to five-fold more common with adalimumab, at 15 percent, compared to 3 percent for placebo. Infection complications were similar in both groups except for a two- to three-fold increase in herpes simplex. Three patients on placebo and six on adalimumab withdrew from the treatment. " http://www.docguide.com/dg.nsf/PrintPrint/E5C244FDA6FD0F0E85256A6C0052E3C3 Re: [ ] D2E7 > I didn't see any mention of side effects either. Did anyone else? > Hugs > Stacey in PA Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.